The University of Arizona

RISE

Summary: 

Comparing the Efficacy of Symbicort® pMDI and Formoterol Turbuhaler in Reducing Exacerbations in Patients With Cronic Obstructive Pulmonary Disease (COPD)

Sponsor: 
AstraZeneca


Research Specialties: 
Pulmonary